To mark upcoming Rare Disease Day, pharmaphorum asked a panel of experts to give their thoughts on the opportunities and challenges facing developers of rare disease therapies in 2024.
When seeking tools for participant retention, payment management, travel, and trial budgeting, considerations for quality may include meeting specific needs.
A survey of people in the UK has found that two thirds (69%) of them would consider taking part in a clinical trial, with a financial incentive the most compelling reason